IE
COV

Israel Englander’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Israel Englander’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-719,521
Closed -$69M – 4607
2014
Q3 		$62.2M Sell
719,521
-263,405
-27% -$23.3M 0.16% 122
2014
Q2 		$88.6M Buy
982,926
+981,726
+81,811% +$73.4M 0.25% 60
2014
Q1 		$88K Buy
+1,200
New +$83.7K ﹤0.01% 3321
2013
Q4 		– Sell
-278,296
Closed -$17M – 4149
2013
Q3 		$17M Sell
278,296
-64,313
-19% -$3.92M 0.05% 429
2013
Q2 		$19.1M Buy
+342,609
New +$19.8M 0.06% 334

Israel Englander's COV Position: Q4 2014 in Review

Israel Englander sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q4 2014, closing a stake of 719,521 shares — an estimated $69M sold.

Israel Englander first reported a position in COV in Q2 2013 and held it in 5 quarters. The position peaked at $88.6M in Q2 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • Israel Englander reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q4 2014 after selling out during the quarter.
  • Israel Englander sold 719,521 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $69M.
  • Israel Englander first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 5 quarters.
  • Israel Englander's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $88.6M in Q2 2014.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Millennium Management's 13F filing for Q4 2014, filed 17 Feb 2015.